Rafferty Asset Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.63M | Sell |
152,978
-10,441
| -6% | -$384K | 0.02% | 375 |
|
|
2025
Q1 | $5.78M | Sell |
163,419
-9,367
| -5% | -$331K | 0.02% | 338 |
|
|
2024
Q4 | $7.56M | Buy |
172,786
+4,947
| +3% | +$216K | 0.03% | 331 |
|
|
2024
Q3 | $7.61M | Sell |
167,839
-17,798
| -10% | -$807K | 0.03% | 328 |
|
|
2024
Q2 | $7.2M | Sell |
185,637
-98,715
| -35% | -$3.83M | 0.03% | 336 |
|
|
2024
Q1 | $9.16M | Sell |
284,352
-80,743
| -22% | -$2.6M | 0.03% | 294 |
|
|
2023
Q4 | $10.5M | Buy |
365,095
+138,153
| +61% | +$3.96M | 0.04% | 264 |
|
|
2023
Q3 | $6.28M | Sell |
226,942
-98,001
| -30% | -$2.71M | 0.04% | 341 |
|
|
2023
Q2 | $8.69M | Sell |
324,943
-2,643
| -0.8% | -$70.7K | 0.05% | 238 |
|
|
2023
Q1 | $7.1M | Buy |
327,586
+90,268
| +38% | +$1.96M | 0.05% | 289 |
|
|
2022
Q4 | $5.65M | Sell |
237,318
-30,535
| -11% | -$727K | 0.05% | 351 |
|
|
2022
Q3 | $5.28M | Buy |
267,853
+164,852
| +160% | +$3.25M | 0.06% | 326 |
|
|
2022
Q2 | $2.01M | Sell |
103,001
-45,621
| -31% | -$889K | 0.02% | 462 |
|
|
2022
Q1 | $3.79M | Sell |
148,622
-8,911
| -6% | -$227K | 0.02% | 440 |
|
|
2021
Q4 | $3.97M | Buy |
157,533
+58,257
| +59% | +$1.47M | 0.02% | 466 |
|
|
2021
Q3 | $2.73M | Buy |
99,276
+23,162
| +30% | +$637K | 0.02% | 535 |
|
|
2021
Q2 | $2.42M | Buy |
76,114
+6,074
| +9% | +$193K | 0.02% | 621 |
|
|
2021
Q1 | $3.21M | Buy |
70,040
+53,992
| +336% | +$2.48M | 0.02% | 442 |
|
|
2020
Q4 | $635K | Sell |
16,048
-2,435
| -13% | -$96.4K | 0.01% | 629 |
|
|
2020
Q3 | $643K | Buy |
+18,483
| New | +$643K | 0.01% | 650 |
|